Illegitimate WNT signaling promotes proliferation of multiple myeloma cells - Wikidata - awgldk - TriplyDB

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

http://www.wikidata.org/entity/Q24568035

about

sameAs

Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling Multiple myeloma cancer stem cells MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner Wnt signalling in stem cells and cancer WNT and beta-catenin signalling: diseases and therapies Stromal fibroblasts in cancer initiation and progression Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin.An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death Osteoblastogenesis and tumor growth in myeloma.Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma.Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model.Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia Pyk2 promotes tumor progression in multiple myeloma Activation of β-catenin signalling leads to temporomandibular joint defects.MUC1 oncoprotein promotes growth and survival of human multiple myeloma cells.β-catenin SUMOylation is involved in the dysregulated proliferation of myeloma cells BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes.Wnt modulates MCL1 to control cell survival in triple negative breast cancer.

P2860

Q21195874-4DAF3CCA-0271-4C2F-A8BF-1340DB97369F Q24632740-58E03319-06EA-412E-A195-C290E1434FA3 Q26752365-5CC20612-5E1C-4296-8F0E-1D9550E52FB1 Q26765477-ED163A50-3CDC-4EF5-9382-4D178C195789 Q26785497-5651D1D1-9C16-47BD-A00D-742CCABDB60D Q27001749-6B75E65F-06C9-4319-8204-D690D3E8CAD4 Q27692033-483B5A6E-5A02-45AB-BC7B-DF3BC21CD787 Q27852536-61E0478B-36AF-45DC-9507-03B707CBC3E1 Q28249838-E9B1FF28-3BB0-4715-B9FC-44ADD1723B4C Q28485498-E8051264-94BE-4D05-BA09-C5B2AA7DE157 Q28543151-E53108D6-79FF-4414-A13D-A9846E43FF5A Q29547862-3482B142-4FC8-4D69-BB0C-51E0B2233E56 Q29616159-871AE42B-942B-44D9-ADB2-469746A04A4E Q29618873-9E455EA2-0DBD-4F4E-902B-B6C52350309B Q33248385-152BC7D5-D687-4B45-BAFA-E6D979432C16 Q33282863-2A8D5395-908E-4359-9ACF-0F22843D57BB Q33426189-256BD810-5C15-4AFA-A22E-D7B00A27BA9C Q33428940-84EC41AC-5611-47E1-BE9B-43229FF174B7 Q33560729-C250B9F5-A5D4-4C55-AE98-DC55009190DA Q33577408-A8D79722-3EBC-46E7-AFD9-0011FA587A9F Q33710200-E397E38A-0BE7-4E91-B378-5C243C935547 Q33768466-7F12894B-C539-40F9-963D-F2B9D0F9E09A Q33856318-103480B2-02FF-4310-854D-505C6C9F0C21 Q34022979-B1DA2186-7DAC-4B05-A2A4-966EA1D65611 Q34036138-9A406FEB-3CF2-44CB-A0D6-D01118660869 Q34038854-857F851F-64DD-4E57-999B-D015CE5A5B98 Q34104277-55FCDB7D-EF8E-4285-9EE2-4D900BA7B3A7 Q34121336-361478BA-27DC-426F-B361-BE25C75DABB5 Q34169968-21180420-AFD6-4A02-9ADA-E3B244351D6C Q34174284-B4B98A3B-0012-4EF4-919E-219D50377CCC Q34287900-7C887832-C1E1-497A-879D-3AC4B7CC816C Q34350571-11ED043D-7701-4B39-9B0E-F0E18ED77D30 Q34393633-6D5DA1F4-095F-4C7A-8957-B2AAA5DB68CD Q34398382-2510879A-6232-41F5-BF57-5CF761BB6602 Q34887363-0A5BE204-BAB5-498E-AF73-8291BFE925EC Q34914713-D56E8B4D-E25B-4C2B-A982-E5874FE2A48F Q34991235-B8174BDC-1770-487D-8A98-DF0D77A533D0 Q35063960-FD158571-2080-4C31-8A4D-1DCE8DE63BD1 Q35071119-8FE7EB3F-F7F7-41BD-BCF5-16E98842EB8F Q35101885-394BE935-B627-4F29-AEF9-4F9FAD5639F1

P2860

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

http://www.wikidata.org/entity/Q24568035

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@ast

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@en

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@nl

type

label

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@ast

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@en

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@nl

prefLabel

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@ast

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@en

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@nl

P1433

Q24568035-4C3D9A3A-61E3-49DA-A69D-BE51C5803EAE

P1476

Q24568035-7EA0BD1C-9BC1-46DB-AF0C-7516192AB360

P2093

Q24568035-037EAEC1-2E50-4954-B056-D143C0CA1CCE

Q24568035-24791D3D-63B0-4693-A157-CEB7C6847606

Q24568035-25B13F14-68C7-4FF1-B4BC-9ABC2ECD839C

Q24568035-5100F885-51AF-4A43-BDD4-58B5138A635B

Q24568035-53F2E2A9-3BB4-4D1F-88FD-96AFF20583D8

Q24568035-8DC3856C-FF46-4CDC-BA5B-44011B6796E1

Q24568035-91E0A74D-814E-4705-A499-002042124355

Q24568035-BA3A1A8E-14E0-48F5-9C69-4F686E266B21

Q24568035-C54464A9-BE8C-45D6-A554-8E79308C9BAE

Q24568035-DA4CBA4F-C38A-4277-B2A7-2D8569543381

P2860

Q24568035-00DC8B6B-7CC7-46AE-9050-2B1FDC173DF7

Q24568035-0783ACD4-19EB-406B-9A5D-D7305562BDEB

Q24568035-095BA5C9-E83A-42A9-899F-A960EB301FDE

Q24568035-0D54771A-3C99-44A9-A5B8-F17D93746E80

Q24568035-1255ABA3-1CF0-4D43-8B00-B85B57DA96CD

Q24568035-189232E6-FC40-401D-B0C0-7E62D95F9FF1

Q24568035-1D40923A-0438-4908-A1E3-8A7B9F24D1F8

Q24568035-1EBB90A3-792D-43D1-BE5A-CBFA60CAA0B2

Q24568035-23516C76-8B63-4E42-8930-9F6B5F2EC571

Q24568035-2388E734-31FA-4CF5-B33F-4DDE61552315

P304

Q24568035-F7665E67-3E86-4DFF-8207-9DBF5C565F87

P31

Q24568035-CBA93BB9-6A19-4C63-B539-5567D1D3A273

P3181

Q24568035-24274A0D-A157-4295-9CD4-83A156369535

P356

Q24568035-54900BA0-9DE9-4468-A51B-78C0B48F08BC

P407

Q24568035-22F5E8F6-E0E0-4A60-91DB-2A1377038E2F

P433

Q24568035-35E4A43E-8909-4320-9998-D30F0D930FA3

P478

Q24568035-FD7ED03F-B008-4621-8512-67D9BE569EE5

P50

Q24568035-445B76AD-59AF-4AA9-AB9F-9A389ADBC9E3

Q24568035-552A1BF2-DC92-4357-908D-DCCA78EC5DCE

P577

Q24568035-6B4C3A7F-61CD-4A59-B9E0-AAD1F12DF7F0

P5875

Q24568035-1A3DE151-6F5F-408B-955D-B763F23A8CFF

P698

Q24568035-FE759924-901B-49F2-961F-24FB8900349E

P932

Q24568035-7BC32502-A53F-4F35-ACE2-8143220D5C8B

P3181

P356

PNAS.0305855101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

@en

P2093

Andries C Bloem

http://www.w3.org/2001/XMLSchema#string

Esther Tjin

http://www.w3.org/2001/XMLSchema#string

Harold D MacGillavry

http://www.w3.org/2001/XMLSchema#string

Helen P Meijer

http://www.w3.org/2001/XMLSchema#string

Henk M Lokhorst

http://www.w3.org/2001/XMLSchema#string

Marinus H J van Oers

http://www.w3.org/2001/XMLSchema#string

Melanie D Klok

http://www.w3.org/2001/XMLSchema#string

Patrick W B Derksen

http://www.w3.org/2001/XMLSchema#string

Roel Nusse

http://www.w3.org/2001/XMLSchema#string

Ronald van der Neut

http://www.w3.org/2001/XMLSchema#string

P2860

Role of members of the Wnt gene family in human hematopoiesis

Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia

Identification of c-MYC as a target of the APC pathway

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

Wnt signaling and cancer

Lessons from hereditary colorectal cancer

Wnt signaling in B-cell neoplasia

P304

6122-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

471259

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0305855101

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Marcel Spaargaren

P577

2004-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8634722

http://www.w3.org/2001/XMLSchema#string

P698

15067127

http://www.w3.org/2001/XMLSchema#string

P932

395933

http://www.w3.org/2001/XMLSchema#string